ACCORD HEALTHCARE, INC. recalls Levothyroxine Sodium Tablets, USP, 125 mcg (0.125 mg), 1000-count bottles, Rx Only, Manufactured for: Accord

What was recalled

The U.S. Food and Drug Administration (FDA) has initiated a Class II recall involving a specific batch of prescription thyroid medication distributed nationwide. This action centers on Levothyroxine Sodium Tablets, USP, with a strength of 125 mcg (0.125 mg). These are not over-the-counter supplements or generic store-brand pills; they are Rx-only medications manufactured by Intas Pharmaceuticals Limited in Selaqui, Dehradun, India, for Accord Healthcare, Inc., which is headquartered in Raleigh, North Carolina. The recall specifically targets 1000-count bottles of this medication, making it distinct from smaller retail packages you might find in a standard pharmacy drawer.

To help you identify whether your bottle is part of this recall, you need to look closely at the labeling on the back or side of the container. The National Drug Code (NDC) for these affected bottles is 16729-453-17. However, the NDC alone does not confirm if your specific bottle is unsafe, as multiple lots may share the same code during different production runs. You must check the lot number and expiration date printed on the label to be certain.

The recall covers four specific lot numbers, each with its own expiration date:

• Lot D2401983: Expiration Date 08/31/2026
• Lots D2402640 and D2402641: Expiration Date 11/30/2026
• Lot D2500224: Expiration Date 01/31/2027

If your bottle of Accord Healthcare’s Levothyroxine Sodium Tablets, USP, 125 mcg matches any of these lot numbers, it is included in the recall. The distribution pattern for this product was nationwide within the United States, meaning these bottles could have been sold to patients in all 50 states, not just North Carolina. The recall was officially announced on August 6, 2026. It is important to note that while the manufacturer and distributor are based in Raleigh, NC, the physical manufacturing took place in India. If you have recently filled a prescription for this specific strength and brand, or if you have an unopened bottle at home, please verify the lot number against the list above immediately.

The hazard, explained

At the heart of this recall is a subtle but significant issue known as a "subpotent" defect. In plain terms, this means that the Levothyroxine Sodium tablets in question are not delivering the full dose of medication they claim to contain on the label. While the bottle says you are taking 125 mcg (0.125 mg) of the active ingredient, the actual amount inside these specific lots may be lower. This is not a matter of contamination or foreign objects; rather, it is a manufacturing variance where the concentration of the drug substance falls below the established standards for strength and quality.

To understand why this matters, it helps to look at how Levothyroxine works in the body. This medication is a synthetic version of thyroxine, a hormone naturally produced by your thyroid gland. Thyroid hormones are the master regulators of your metabolism, controlling how fast your heart beats, how efficiently you burn calories, and how your brain functions. Unlike many other medications where a slightly lower dose might just mean "it works a bit slower," Levothyroxine has a very narrow therapeutic window. This means the difference between a helpful dose and an ineffective one is incredibly small.

When a patient takes a subpotent tablet, their body effectively goes into a state of relative hypothyroidism, even if they are taking the medication exactly as prescribed. The thyroid hormone levels in the blood drop below the target range because the external supply is insufficient to meet the body’s metabolic demands. This isn't an immediate emergency for most people in the short term, but it creates a slow, creeping deficit that can have serious cumulative effects on your health.

The physical mechanism of harm here is biochemical starvation. Your cells are essentially being asked to run an engine with too little fuel. Over time, this inadequacy disrupts multiple bodily systems. The most common result is a return of the symptoms that led you to take the medication in the first place: profound fatigue, unexplained weight gain, sensitivity to cold, and brain fog. However, the risks extend beyond just feeling tired. Chronic under-treatment of thyroid function can lead to elevated cholesterol levels, which increases the risk of heart disease. In more severe cases, it can cause heart enlargement or fluid buildup around the heart (pericardial effusion). For pregnant individuals, the stakes are even higher, as adequate thyroid hormone is critical for the baby’s brain development.

Because this defect is based on potency rather than visible appearance, you cannot tell if a pill is subpotent by looking at it. The tablets may look identical to safe ones. This makes the recall particularly insidious because patients may continue their routine without realizing their treatment is failing until significant health changes occur. Understanding this mechanism highlights why regulatory agencies take drug potency issues so seriously—it undermines the very foundation of medical treatment, which relies on the assurance that what is on the label is exactly what is in the bottle.

Who is most at risk

The individuals most directly affected by this recall are those who have been prescribed Levothyroxine Sodium Tablets, USP, 125 mcg (0.125 mg) by Accord Healthcare, specifically those holding the 1000-count bottles with the lot numbers D2401983, D2402640, D2402641, or D2500224. Because this medication is a prescription-only drug used to treat hypothyroidism—a condition where the thyroid gland does not produce enough thyroid hormone—the population at risk is defined by their medical necessity for precise hormonal balance. Levothyroxine is a synthetic form of the thyroid hormone thyroxine (T4), and its primary role is to restore, maintain, or supplement adequate levels of this hormone in the body. Consequently, the people using these specific recalled bottles are individuals who rely on this medication to regulate their metabolism, heart rate, body temperature, and energy levels.

The severity of the risk associated with a "subpotent" drug like this one is not uniform across all patients; it varies significantly based on individual physiology, the stability of their condition, and how strictly they adhere to their dosage regimen. For many adults with well-managed hypothyroidism, a slight reduction in potency may result in a gradual return of symptoms rather than an immediate medical emergency. These individuals might experience fatigue, weight gain, sensitivity to cold, or difficulty concentrating. However, for others, the margin for error is far narrower. Elderly patients, in particular, are often more sensitive to changes in thyroid hormone levels. Even a subtle decrease in effective dosage can place undue stress on the cardiovascular system, potentially leading to complications such as irregular heartbeats (arrhythmias) or worsening heart failure, especially if the patient has pre-existing heart conditions.

Certain groups face heightened vulnerability due to the critical nature of thyroid hormone regulation during specific life stages or health crises. Pregnant women are a primary concern because thyroid hormones are essential for fetal brain development, particularly in the first trimester when the fetus relies entirely on the mother’s supply. A subpotent dose could theoretically impact developmental outcomes, making timely intervention crucial. Similarly, patients with severe, long-standing hypothyroidism or those who have recently undergone thyroid surgery or radioactive iodine treatment may not have enough residual thyroid function to compensate for the lower potency of the recalled tablets. For these individuals, the gap between the expected therapeutic dose and the actual amount received could lead to a rapid decline in health, manifesting as myxedema—a rare but serious condition characterized by extreme lethargy, hypothermia, and confusion.

It is also important to recognize that the risk extends beyond just physical symptoms. The psychological impact of untreated or under-treated hypothyroidism can be significant, affecting mood stability and cognitive function. Patients who depend on this medication for daily functioning may find their quality of life diminished as hormone levels drop. Furthermore, because the recall involves a high-volume distribution (1000-count bottles) across the nation, there is a risk that patients in different states may have received the product without immediate awareness. This geographic spread means that individuals who have not recently visited their pharmacy or checked their specific lot numbers are at risk of unknowingly continuing to use subpotent medication. Therefore, the most vulnerable group includes anyone who has filled this prescription since August 2026 and has not yet verified the lot number on their bottle against the recall list.

How to tell if you have the recalled item

When dealing with a medication recall, specifically one involving subpotent drugs like the Levothyroxine Sodium Tablets issued by Accord Healthcare, Inc., visual inspection alone is rarely enough to guarantee safety. Because these tablets are manufactured for Accord and produced by Intas Pharmaceuticals Limited in India, they may look identical to non-recalled batches of the same strength. Therefore, you must rely on specific alphanumeric codes printed directly on the packaging rather than just the drug name or strength. The FDA has identified a very narrow set of distribution details for this Class II recall, which occurred on August 6, 2026. To determine if your bottle is part of this issue, you need to locate the National Drug Code (NDC) and the specific lot numbers associated with the affected expiration dates.

First, look at the side or back label of your prescription bottle. You are looking for the NDC number 16729-453-17. This code identifies the specific product configuration: Levothyroxine Sodium Tablets, USP, at a strength of 125 mcg (0.125 mg), packaged in 1000-count bottles. It is important to note that this recall applies strictly to these large-volume bottles distributed nationwide within the United States. If you have a smaller bottle, such as a standard 30 or 90-count prescription vial from a different batch, it is likely not affected, but you should still verify the lot number to be absolutely certain.

The most critical step is checking the Lot Number and Expiration Date, which are printed together on the label. The recall encompasses four specific lot numbers across three expiration windows. You must check your bottle against this exact list:

• Lot # D2401983: Check if the expiration date is 08/31/2026.
• Lot # D2402640: Check if the expiration date is 11/30/2026.
• Lot # D2402641: Check if the expiration date is 11/30/2026.
• Lot # D2500224: Check if the expiration date is 01/31/2027.

If your bottle matches both the NDC 16729-453-17 and one of the lot numbers listed above, do not take the medication. Because the hazard is a "subpotent" drug, the tablets may contain less active ingredient than labeled. This is particularly dangerous for Levothyroxine, a hormone replacement medication used to treat hypothyroidism. A lower dose can lead to ineffective treatment, causing your thyroid levels to drop and potentially leading to fatigue, weight gain, and other metabolic issues. If you do not see these specific codes, your medication is safe to use, but if you are unsure or cannot find the lot number on an older bottle, contact your pharmacist immediately for assistance in verifying its status.

What to do — step by step

If you have been taking Levothyroxine Sodium Tablets manufactured by Accord Healthcare, Inc., it is completely understandable to feel a mix of concern and urgency right now. Because this specific recall involves a "subpotent" drug—meaning the medication may not contain the full amount of active ingredient listed on the label—your immediate actions are critical for maintaining your health stability. Please do not panic, but do act with care. The FDA has issued this Class II recall because while the situation is serious and requires prompt attention, it is unlikely to cause severe or permanent harm if managed correctly. Since the official remedy details were not explicitly stated in the initial recall announcement, you must take proactive steps to secure your health and resolve the issue with the manufacturer.

First and foremost, stop taking these specific tablets immediately. Do not finish the bottle even if you have only taken a few doses. The inconsistency in potency means your body is not receiving the precise thyroid hormone regulation it needs. Levothyroxine has a narrow therapeutic index, which means small changes in dosage can lead to significant fluctuations in your health. Continuing to use a subpotent version could cause your thyroid levels to drop, leading to symptoms like fatigue, weight gain, and depression, or worse, mask the severity of your condition until it becomes dangerous. Put the bottle aside in a place where you will not accidentally take another dose.

Next, contact your prescribing healthcare provider right away. This is the most important medical step you can take. Do not attempt to adjust your dosage on your own or switch to a different brand without professional guidance. Your doctor needs to know exactly which lot numbers you were using—specifically D2401983, D2402640, D2402641, or D2500224—and for how long. They may want to run blood tests to check your thyroid-stimulating hormone (TSH) and free T4 levels to ensure your treatment plan remains effective. They can also help you transition to a non-recalled batch of the same medication or an equivalent alternative, ensuring there is no gap in your care.

After speaking with your doctor, contact Accord Healthcare, Inc., the company responsible for the recall. The official remedy details were not stated in the provided recall facts, which means you must reach out directly to them to understand how they are handling returns or replacements. Call their customer service line and provide your name, address, and the lot numbers on your bottle. Ask specifically if they are offering a refund, a replacement product from a different batch, or instructions on how to return the medication safely. Keep a record of this conversation, including the date, time, and the name of the representative you spoke with.

Finally, retain the original packaging and the bottle itself until you have received clear instructions from Accord Healthcare. Do not throw it away yet, as they may need to verify the lot number or arrange for its disposal. If they ask you to return the product, follow their shipping instructions precisely. This helps them track the scope of the issue and ensures that no other patients are affected by these specific batches. By taking these steps calmly and methodically, you protect your health and contribute to the broader effort to keep everyone safe.

Your refund, repair, or replacement options

One of the most immediate concerns when you discover a medication is subject to an official recall is the practical question of how to resolve the issue without compromising your health or incurring unnecessary financial loss. In this specific case involving Accord Healthcare, Inc., the FDA recall notice for Levothyroxine Sodium Tablets, USP, 125 mcg presents a somewhat unusual situation regarding consumer remedies. It is important to approach this with clarity and calmness, understanding that the standard pathways for refunds or replacements are not explicitly detailed in the current public report.

The official FDA documentation for this Class II recall does not state a specific remedy, such as a direct refund, a repair process, or a guaranteed replacement product. When a recall notice omits these details, it typically means that the standard procedure relies heavily on your relationship with the healthcare provider who prescribed the medication and the pharmacy that dispensed it. Because Levothyroxine is a prescription-only drug (Rx Only), you do not have the option to simply return the bottle to a retail store counter like you might with over-the-counter goods. Instead, the primary "remedy" available to you right now is professional medical guidance.

Your first and most critical step is to contact the pharmacy where you purchased or filled your prescription for the affected lots. Pharmacies are required to handle recalled medications according to strict federal guidelines. They will likely isolate the product to prevent further dispensing and can guide you on how to return it properly. While the recall notice does not explicitly promise a refund, pharmacies generally have established protocols for crediting accounts or voiding transactions for recalled drugs. You should ask them specifically about their policy for this Accord Healthcare batch.

Equally important is contacting your prescribing physician. Levothyroxine is a hormone replacement medication used to treat thyroid conditions, and its effectiveness is critical for your daily well-being. Because the hazard here is that the drug is "subpotent" (meaning it may not contain the full amount of active ingredient indicated on the label), simply stopping the medication or swapping bottles without supervision can be risky. Your doctor needs to know you have this specific lot so they can monitor your thyroid levels and, if necessary, prescribe a different manufacturer’s product immediately. This ensures continuity of care while the recall issue is resolved.

If you are seeking financial restitution, it is worth noting that the FDA classifies this as a Class II recall, indicating that use of the product may cause temporary health problems or pose a slight probability of serious harm. While the government does not process refunds directly, your pharmacy or healthcare provider’s billing department should be able to reverse the charge for the recalled item. If you paid out-of-pocket, keep your receipt and the lot number information handy. When you speak with customer service at your pharmacy chain, reference the specific NDC 16729-453-17 and the affected lot numbers (D2401983, D2402640, D2402641, or D2500224) to ensure they are processing the correct transaction.

In summary, while there is no single "refund center" listed for this recall, the path forward is straightforward through your existing healthcare network. Prioritize your health by consulting your doctor to ensure your dosage remains effective with a different source, and let your pharmacy handle the logistics of returning the product and adjusting your bill. Do not attempt to dispose of the medication yourself; follow the instructions given by your pharmacist to ensure safe disposal.

What can happen if you ignore it

Staying safe: broader tips

Medications like levothyroxine are critical for maintaining metabolic balance, and because their effectiveness depends on precise chemical composition, staying vigilant about product quality is a vital part of your long-term health management. While you cannot test the potency of a pill at home, there are several proactive steps you can take to ensure that every medication you swallow meets federal safety standards. The most effective strategy is to establish a routine for verifying drug recalls. The FDA maintains a comprehensive, searchable database of all active recalls, categorized by agency and industry. By bookmarking the FDA’s recall page or signing up for their email alerts, you can receive timely notifications before a potentially unsafe product reaches your pharmacy shelf. This proactive approach transforms you from a passive consumer into an informed participant in your own safety net.

Another essential habit is to maintain clear and organized records of the medications you take. Keep a simple log or use a dedicated app to track the National Drug Code (NDC), lot numbers, and expiration dates of your prescriptions. This documentation becomes invaluable during a recall event, allowing you to quickly identify whether your specific bottles are affected without needing to dig through old receipts or guess at manufacturing details. When you do this, you also make it easier for your healthcare provider to adjust your treatment plan if a substitution is necessary. Always verify the source of your medications as well; purchasing from licensed pharmacies and avoiding online marketplaces that do not require valid prescriptions reduces the risk of receiving counterfeit or improperly stored drugs.

Communication with your healthcare team is equally important. Never hesitate to ask your pharmacist about the manufacturer of your current prescription, especially if you notice changes in how a medication looks, smells, or behaves compared to previous fills. Pharmacists are accessible health professionals who can provide immediate context regarding supply chain issues or known quality concerns. Additionally, stay informed about general drug safety education. Understanding how environmental factors like humidity and heat can degrade pharmaceuticals helps you store your medications correctly, preserving their integrity until the moment of use. By combining these general safety habits with official recall information, you create a robust layer of protection around your health, ensuring that you remain informed, prepared, and safe regardless of unexpected supply chain disruptions.